Observational study of XELOX in combination with bevacizumab for advanced or recurrent colorectal cancer
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms KPUMDS C-01
- 28 Jul 2015 Status changed from active, no longer recruiting to completed as per University Hospital Medical Information Network - Japan record.
- 01 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Feb 2011 New trial record